A series of benzodiazepines and benzazepinones were synthesized and evaluated as potential sodium channel blockers in a functional, membrane potential-based assay. One member of the benzazepinone series, compound 47, displayed potent, state-dependent block of hNa(v)1.7, and was orally efficacious in a rat model of neuropathic pain.
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Publishing Authors By Initials
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Bioorganic & medicinal chemistry letters
VOLUME: 17
Page Numbers: 4630-4
Journal Abbreviation: Bioorg. Med. Chem. Lett.
ISSN: 0960-894X
DAY: 27
MONTH: 05
YEAR: 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9107377
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Keywords Mesh Terms:
KEYWORDS: Structure-Activity Relationship
MESH TERMS: metabolism
Chemical & Substance for Abstract: Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Information
Substance Name: Sodium Channels
Registry Number: 0
Grant and Affiliation Information for Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
AFFILIATION: Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. scott_hoyt@merck.com
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Bioorg Med Chem Lett
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Discovery of a novel class of benzazepinone Nav17 blockers: potential treatments for neuropathic pain Related Publications